PMID: 7992355Dec 15, 1994Paper

The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft

Transplantation
C SerrickH Shennib

Abstract

A period of cold and warm ischemia is obligatory when performing lung transplantation. Subtle ischemia-reperfusion injury induced in the course of transplantation can pass undetected or cause a short phase of reversible lung dysfunction. We hypothesized that ischemia-reperfusion injury may result in the local release of cytokines that have the capability to mediate acute lung injury early following transplantation. To test this hypothesis, 10 mongrel dogs were subjected to left lung allotransplantation. As performed in the clinical setting, donor lungs were preserved with Eurocollins solution and stored at 4 degrees C for 4 hr, which was followed by 1 hr of warm ischemia. Recipients received standard immunosuppression of cyclosporine, azathioprine, and low dose steroids. Bronchoalveolar lavage (BAL) and open lung biopsies were performed before operation and at approximately 1 hr, 4 hr, 24 hr, and 1 week after transplantation. A significant increase in BAL IL-2 levels was observed 4 hr after surgery (0 hr: 349 +/- 138 pg/ml; 4 hr: 757 +/- 284 pg/ml) (mean +/- SEM) (P < 0.05) which subsequently decreased 24 hr (320 +/- 168 pg/ml) after transplantation. BAL TNF-alpha levels were significantly increased 1 hr after transplantation (...Continue Reading

Citations

Mar 31, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Rosanna Di Paola, Salvatore Cuzzocrea
May 18, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Kiyohiro OshimaYasuo Morishita
Dec 20, 2000·Transplantation Proceedings·K OshimaY Morishita
Dec 20, 2000·Transplantation Proceedings·Y SunoseY Morishita
Dec 5, 1998·Transplantation Proceedings·Y OtaniY Morishita
Dec 29, 1998·Transplantation Proceedings·S Massberg, K Messmer
Mar 20, 1999·Transplantation Proceedings·Y OtaniY Morishita
Apr 25, 2000·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Y OtaniY Morishita
Jul 30, 2011·American Journal of Respiratory and Critical Care Medicine·David J LedererUNKNOWN Lung Transplant Outcomes Group
Aug 1, 2007·Biomarkers in Medicine·Carolyn S Calfee, Lorraine B Ware
Jul 4, 2013·Seminars in Respiratory and Critical Care Medicine·Yoshikazu SuzukiJason D Christie
Nov 30, 1999·The International Journal of Angiology : Official Publication of the International College of Angiology, Inc·K OshimaY Morishita
Apr 23, 2011·Clinics in Chest Medicine·James C Lee, Jason D Christie
Jun 27, 2013·Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia·Takashi EguchiKazuo Yoshida
Jul 1, 2008·Transplantation Proceedings·S Martìn-SuàrezG Arpesella
Nov 1, 2001·Radiology·E M MaromH P McAdams
Feb 18, 2003·American Journal of Respiratory and Critical Care Medicine·Marc de PerrotShaf Keshavjee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.